Department of Pediatrics, Faculty of Medicine, Ain Shams University, Cairo, Egypt.
Department of Pediatrics, Faculty of Medicine, Assiut University, Assiut, 71516, Egypt.
Metab Brain Dis. 2017 Dec;32(6):1935-1941. doi: 10.1007/s11011-017-0088-z. Epub 2017 Aug 14.
Many diet regimens were studied for patients with autism spectrum disorder (ASD) over the past few years. Ketogenic diet is gaining attention due to its proven effect on neurological conditions like epilepsy in children. Forty-five children aged 3-8 years diagnosed with ASD based on DSM-5 criteria were enrolled in this study. Patients were equally divided into 3 groups, first group received ketogenic diet as modified Atkins diet (MAD), second group received gluten free casein free (GFCF) diet and the third group received balanced nutrition and served as a control group. All patients were assessed in terms of neurological examination, anthropometric measures, as well as Childhood Autism Rating Scale (CARS), Autism Treatment Evaluation Test (ATEC) scales before and 6 months after starting diet. Both diet groups showed significant improvement in ATEC and CARS scores in comparison to control group, yet ketogenic scored better results in cognition and sociability compared to GFCF diet group. Depending on the parameters measured in our study, modified Atkins diet and gluten free casein free diet regimens may safely improve autistic manifestations and could be recommended for children with ASD. At this stage, this study is a single center study with a small number of patients and a great deal of additional wide-scale prospective studies are however needed to confirm these results.
UMIN-CTR Study Design: trial Number UMIN000021433.
近年来,许多饮食方案都在自闭症谱系障碍(ASD)患者中进行了研究。生酮饮食由于其对儿童癫痫等神经疾病的疗效而受到关注。本研究纳入了 45 名符合 DSM-5 标准的 3-8 岁 ASD 患儿。患者分为三组,第一组接受改良后的阿特金斯饮食(MAD)作为生酮饮食,第二组接受无谷蛋白无酪蛋白饮食(GFCF),第三组接受均衡营养作为对照组。所有患者在开始饮食前和 6 个月后进行神经检查、人体测量以及儿童自闭症评定量表(CARS)、自闭症治疗评估量表(ATEC)评估。与对照组相比,两种饮食组的 ATEC 和 CARS 评分均有显著改善,但与 GFCF 饮食组相比,生酮饮食在认知和社交方面的效果更好。根据本研究测量的参数,改良阿特金斯饮食和无谷蛋白无酪蛋白饮食方案可能安全地改善自闭症症状,并可推荐用于 ASD 儿童。在现阶段,本研究是一项单中心研究,患者数量较少,但需要进行大量额外的大规模前瞻性研究来证实这些结果。
UMIN-CTR 研究设计:试验号 UMIN000021433。